MakeMyTrip (MMYT) Registers a Bigger Fall Than the Market: Important Facts to Note

MakeMyTrip (MMYT) recently underperformed the market, with its stock falling 5.07% on the day and lagging broader indices and its sector over the past month. Analysts project strong upcoming earnings, with Q1 EPS expected to grow 25% to $0.45 and revenue by 25.26% to $264.28 million, alongside robust full-year growth forecasts. However, MMYT holds a Zacks Rank of #3 (Hold) and trades at a significant forward P/E of 47.16, a substantial premium to its industry average of 16.02, despite stagnant recent consensus EPS estimate revisions.

Analysis

MakeMyTrip (MMYT) is exhibiting a clear disconnect between its recent stock performance and its forward-looking fundamental expectations. The stock's recent 5.07% single-day decline and 0.39% loss over the past month represent significant underperformance relative to both the S&P 500 and the broader Computer and Technology sector, which gained 9.88% in the same period. This negative price action contrasts sharply with robust analyst consensus estimates for the upcoming quarter, which project 25% year-over-year EPS growth to $0.45 and a 25.26% increase in revenue to $264.28 million. The full-year outlook is similarly strong, with expected EPS and revenue growth of 38.46% and 21.79%, respectively. However, two key factors temper this bullish outlook: the stock's valuation and the trajectory of analyst revisions. MMYT trades at a forward P/E of 47.16, a steep premium to its industry average of 16.02, indicating that high expectations are already priced in. Furthermore, despite the strong growth forecasts, the Zacks Consensus EPS estimate has remained stagnant over the past month, a potential signal that analyst optimism may be plateauing. This combination of factors underpins the stock's neutral Zacks Rank of #3 (Hold).

Key Decisions for Investors

• Investors should recognize that MMYT's high forward P/E of 47.16 sets a very high bar for its upcoming earnings, making the stock vulnerable to a significant price correction if it fails to meet or convincingly beat expectations.
• The stagnation in analyst EPS estimate revisions, despite strong headline growth forecasts, warrants caution and close monitoring, as it may signal emerging near-term headwinds or a peak in positive sentiment.
• Given the stock's recent underperformance and neutral 'Hold' rating, a prudent approach would be to await the upcoming earnings report for confirmation of the growth narrative and a potential catalyst before committing new capital.